English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

Parkinson’s disease (PD) impairs motor and non-motor functions. Driver strategies to compensate for impairments, like avoiding driving in risky environments, may reduce on-road risk at the cost of decreasing driver mobility, independence, and quality of life (QoL). It is unclear how PD symptoms link to driving risk exposure, strategies, and QoL. We assessed associations between PD symptoms and driving exposure (1) overall, (2) in risky driving environments, and (3) in relationship to QoL. Twenty-eight drivers with idiopathic PD were assessed using the Movement Disorders Society–Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) and RAND 36-Item Short Form Health Survey (SF-36). Real-world driving was monitored for 1 month. Overall driving exposure (miles driven) and risky driving exposure (miles driven in higher risk driving environments) were assessed across PD symptom severity. High traffic, night, and interstate roads were considered risky environments. 18,642 miles (30,001 km) driven were collected. Drivers with PD with worse motor symptoms (MDS-UPDRS Part III) drove more overall ( b  = 0.17,  P  &lt; .001) but less in risky environments (night:  b  = −0.35,  P  &lt; .001; interstate roads:  b  = −0.23,  P  &lt; .001; high traffic:  b  = −0.14,  P  &lt; .001). Worse non-motor daily activities symptoms (MDS-UPDRS Part I) did not affect overall driving exposure ( b  = −0.05,  P  = .43) but did affect risky driving exposure. Worse non-motor daily activities increased risk exposure to interstate ( b  = 0.36,  P  &lt; .001) and high traffic ( b  = 0.09,  P  = .03) roads while reducing nighttime risk exposure ( b  = −0.15,  P  = .01). Daily activity impacts from motor symptoms (MDS-UPDRS Part II) did not affect distance driven. Reduced driving exposure (number of drives per day) was associated with worse physical health–related QoL ( b  = 2.87,  P  = .04). Results provide pilot data revealing specific PD symptom impacts on driving risk exposure and QoL. Drivers with worse non-motor impairments may have greater risk exposure. In contrast, drivers with worse motor impairments may have reduced driver risk exposure. Reduced driving exposure may worsen physical health–related QoL. Results show promise for using driving to inform clinical care.

Digital driving data can track driving exposure and quality of life in Parkinson’s disease